Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sorafenib and Ifosfamide in Sarcoma
NCT00880542Phase 2Terminated
- Sponsor
- UCLA Jonsson Comprehensive Cancer Center
- Start
- Aug 2008
- Primary completion
- Nov 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sorafenib in sarcoma, sponsored by UCLA Jonsson Comprehensive Cancer Center. Started Aug 2008; status: terminated.
02
Drugs
sorafenib
03
Conditions
sarcoma
Beyond the preview
Go deeper on NCT00880542.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00880542.